🇺🇸 FDA
Company

INOVIO

INOVIO PHARMACEUTICALS, INC.

INO pharma USA

Quick answer

INOVIO is a pharma company (INO) headquartered in PLYMOUTH MEETING, PA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

INO-4800

Coronavirus Infection

Phase 3 · small_molecule · completed

4 trials project

Medpulser Electroporation with Bleomycin

Head Neck Cancer

Phase 3 · other · terminated

1 trials project

VGX-3100

Cervical Dysplasia

Phase 3 · mab · completed

2 trials project

CHRONVAC-C®

Chronic Hepatitis C Virus Infection

Phase 2 · small_molecule · active

1 trials project

ChronVac-C + SOC

Chronic Hepatitis C

Phase 2 · small_molecule · active

1 trials project

GLS-5300

Healthy

Phase 2 · mab · completed

2 trials project

HPV DNA Plasmids Therapeutic Vaccine VGX-3100

Anal Intraepithelial Neoplasia

Phase 2 · mab · completed

1 trials project

INO-3107

Respiratory Papillomatosis

Phase 2 · small_molecule · completed

1 trials project

INO-3112

Cervical Cancer

Phase 2 · mab · completed

1 trials project

INO-3112

Head and Neck Squamous Cell Cancer

Phase 2 · mab · completed

1 trials project

INO-3112 vaccine

Uterine Cervical Neoplasms

Phase 2 · mab · terminated

1 trials project

INO-4700

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Phase 2 · small_molecule · completed

1 trials project

INO-5401

Urothelial Carcinoma

Phase 2 · mab · completed

1 trials project

INO-5401

Glioblastoma

Phase 2 · mab · active

1 trials project

PENNVAX-GP

HIV-1-infection

Phase 2 · mab · completed

1 trials project

VGX 3100

Cervical Intraepithelial Neoplasia

Phase 2 · mab · completed

1 trials project

VGX-3100

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

Phase 2 · mab · completed

1 trials project

VGX-3100

Anal Neoplasm

Phase 2 · mab · completed

1 trials project

p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine

Leukaemia (Acute)

Phase 2 · mab · completed

1 trials project

2mg INO-5150 and electroporation device CELLECTRA®-5P

Prostate Cancer

Phase 1 · mab · completed

1 trials project

Electroporation-Mediated Plasmid DNA Vaccine Therapy

Chronic Hepatitis

Phase 1 · mab · active

1 trials project

FVH1 - a DNA-based influenza vaccine

Influenza, Human

Phase 1 · mab · completed

1 trials project

GLS-5700

Healthy

Phase 1 · mab · completed

2 trials project

GLS-6150

HCV Infection

Phase 1 · mab · completed

1 trials

Patents (8)

patent

US 12285473

Cancer vaccines targeting MUC16 and uses thereof

Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12280108

Vaccines having an antigen and interleukin-21 as an adjuvant

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12251561

Minimally invasive dermal electroporation device

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12240872

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefro

Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12161706

Cancer vaccines targeting BORIS and uses thereof

Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12109258

Synthetic malaria immunogens, combinations thereof, and their use to prevent and

Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12064473

Cancer vaccines targeting Survivin and uses thereof

Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12054537

Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial v

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)